Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trialShaji Kumar, Philippe Moreau, Elizabeth A. Punnoose et al.|The Lancet Oncology|2020Cited by 401
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive modelPau Montesinos, Miguel Á. Sanz, I Di Lorenzo et al.|Haematologica|2007Cited by 225
Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patientsJaime Sanz, Miguel Á. Sanz, F Arriaga et al.|Bone Marrow Transplantation|2007Cited by 100
Cord Blood Transplantation from Unrelated Donors in Adults with High-Risk Acute Myeloid LeukemiaJaime Sanz, Guillermo Sanz, Miguel Á. Sanz et al.|Biology of Blood and Marrow Transplantation|2009Cited by 78
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantationNoemí Puig, Miguel Á. Sanz, Javier de la Rubia et al.|Leukemia & lymphoma/Leukemia and lymphoma|2006Cited by 69